JP2022551499A5 - - Google Patents

Info

Publication number
JP2022551499A5
JP2022551499A5 JP2022521440A JP2022521440A JP2022551499A5 JP 2022551499 A5 JP2022551499 A5 JP 2022551499A5 JP 2022521440 A JP2022521440 A JP 2022521440A JP 2022521440 A JP2022521440 A JP 2022521440A JP 2022551499 A5 JP2022551499 A5 JP 2022551499A5
Authority
JP
Japan
Prior art keywords
approximately
weight
formulation according
cps
ear
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022521440A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022551499A (ja
JP7680653B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/054770 external-priority patent/WO2021072063A1/en
Publication of JP2022551499A publication Critical patent/JP2022551499A/ja
Publication of JP2022551499A5 publication Critical patent/JP2022551499A5/ja
Priority to JP2025051291A priority Critical patent/JP2025098165A/ja
Application granted granted Critical
Publication of JP7680653B2 publication Critical patent/JP7680653B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022521440A 2019-10-11 2020-10-08 耳用製剤、方法およびデバイス Active JP7680653B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025051291A JP2025098165A (ja) 2019-10-11 2025-03-26 耳用製剤、方法およびデバイス

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962914301P 2019-10-11 2019-10-11
US62/914,301 2019-10-11
PCT/US2020/054770 WO2021072063A1 (en) 2019-10-11 2020-10-08 Otic formulations, methods and devices

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025051291A Division JP2025098165A (ja) 2019-10-11 2025-03-26 耳用製剤、方法およびデバイス

Publications (3)

Publication Number Publication Date
JP2022551499A JP2022551499A (ja) 2022-12-09
JP2022551499A5 true JP2022551499A5 (https=) 2023-09-13
JP7680653B2 JP7680653B2 (ja) 2025-05-21

Family

ID=75383696

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022521440A Active JP7680653B2 (ja) 2019-10-11 2020-10-08 耳用製剤、方法およびデバイス
JP2025051291A Pending JP2025098165A (ja) 2019-10-11 2025-03-26 耳用製剤、方法およびデバイス

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025051291A Pending JP2025098165A (ja) 2019-10-11 2025-03-26 耳用製剤、方法およびデバイス

Country Status (6)

Country Link
US (3) US11986483B2 (https=)
EP (1) EP4041153A4 (https=)
JP (2) JP7680653B2 (https=)
CN (3) CN114450010A (https=)
AU (2) AU2020361511B2 (https=)
WO (1) WO2021072063A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114450010A (zh) * 2019-10-11 2022-05-06 皮埃蒙特动物健康公司 耳用制剂、方法和装置

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070078116A1 (en) 2003-08-20 2007-04-05 Fairfield Clinical Trials, Llc Method of treatment of otitis externa
US8003616B2 (en) 2004-04-23 2011-08-23 Albert Rory J Composition for the treatment of ear infections and method
US7858115B2 (en) 2004-06-24 2010-12-28 Idexx Laboratories Phospholipid gel compositions for drug delivery and methods of treating conditions using same
JP4792032B2 (ja) * 2004-08-13 2011-10-12 シェーリング−プラウ・リミテッド 抗生物質、トリアゾールおよびコルチコステロイドを含む薬学的処方物
US8318817B2 (en) * 2008-07-21 2012-11-27 Otonomy, Inc. Controlled release antimicrobial compositions and methods for the treatment of otic disorders
UA111147C2 (uk) * 2009-11-11 2016-04-11 Байєр Б.В. Способи та композиції для лікування або профілактики зовнішнього отиту
PL2802209T3 (pl) 2012-01-10 2021-07-05 Entrx LLC Preparaty do uszu
US9849126B2 (en) * 2013-01-03 2017-12-26 Entrx LLC Sterile otic formulations
US20160058775A1 (en) * 2013-04-12 2016-03-03 Vyome Biosciences Pvt. Ltd. Composition and formulation of antimicrobial agents, processes thereof and methods for treating microbial infections
CN114450010A (zh) * 2019-10-11 2022-05-06 皮埃蒙特动物健康公司 耳用制剂、方法和装置

Similar Documents

Publication Publication Date Title
JP2016510329A5 (https=)
DK2403503T3 (en) Methods for the treatment of ocular inflammatory diseases
JP2009534387A5 (https=)
US20080318843A1 (en) Device and Method for the Delivery of Drugs for the Treatment of Posterior Segment Disease
EP2726081A2 (en) Methods of treating recurrent meibomian glands disorder and thereby decreasing the frequency of recurrence
JP2011526609A5 (https=)
EP3267978B1 (en) Topical compositions comprising a corticosteroid
HRP20201307T1 (hr) Upotreba reslizumaba za liječenje umjerene do ozbiljne eozinofilne astme
EP2547325B1 (en) Spray-pumpable composition suitable for topical skin application
JP2023546361A5 (https=)
JPH06128159A (ja) 外用剤
JP2022551499A5 (https=)
JP2006518382A (ja) 眼の障害に罹患している人を処置するためのステロイドの使用
JP2006518382A5 (https=)
AU2026201359A1 (en) Otic formulations, methods and devices
DE60121047T2 (de) Pharmazeutische zusammensetzung zur behandlung von phimose mit einem topischen corticosteroid
WO2010109424A1 (en) A medicinal antibacterial and steroids cream comprising chitosan and a process to make it
JP2011529904A5 (https=)
WO2015105652A1 (en) Methods for treatment of postoperative inflammation with reduced intraocular pressure
US8722102B2 (en) Compositions for treatment of skin and ear infections
WO2004073608A2 (en) Formulations of glucocorticoids to treat pathologic ocular angiogenesis
JP5189093B2 (ja) 過剰瘢痕化の治療および予防
JP2024516886A5 (https=)
IL312514A (en) Corticosteroid reduction in treatment with anti-cd38 antibodies
JP2024527001A5 (https=)